BioCentury | Mar 6, 2021
Politics, Policy & Law

PTAB expected to get a Supreme pass

...operate, such as the International Trade Commission (ITC...
BioCentury | Oct 20, 2014
Company News

Xagenic management update

...CEO and a director, formerly president and CEO of Accumetrics Inc. , which merged with ITC Nexus Holding Co....
BioCentury | May 5, 2014
Company News

Acasti, Enzymotec, Neptune Technologies nutraceuticals news

...agreement related to Neptune's patents for marine omega-3 phospholipids , ending an International Trade Commission (ITC...
...products infringed the '348 patent, along with Neptune's U.S. Patent Nos. 8,278,351 and 8,383,675. The ITC...
BioCentury | Feb 3, 2014
Emerging Company Profile

2bind: Results within minutes

...said sample prep for standard approaches, such as surface plasmon resonance (SPR), isothermal titration calorimetry (ITC...
...interaction under multiple reaction conditions. This is generally not the case for analysis via SPR, ITC...
...crude extracts such as sera and lysates, whereas trying to do so with SPR or ITC...
BioCentury | Nov 21, 2011
Company News

ITC, Samsung Electronics Co. Ltd. deal

...Samsung will acquire the Nexus Dx Inc. division of ITC for an undisclosed amount. ITC said...
...monitoring cardiovascular diseases. The deal is expected to close this quarter. Terms were not disclosed. ITC...
BioCentury | Oct 6, 2011
Distillery Techniques

Technology: Drug platforms

...Okano, Keio University, Tokyo, Japan e-mail: hidokano@a2.keio.jp Contact: Masaya Nakamura, same affiliation as above e-mail: masa@sc.itc.keio.ac.jp BC...
BioCentury | Nov 15, 2010
Company News

Nexus Dx Inc., Thoratec, Warburg Pincus deal

...sold its International Technidyne Corp. (ITC) subsidiary to Warburg Pincus for $55 million in cash. ITC...
...merged with Warburg-investment Nexus Dx. Nexus said the deal will expand its point-of-care diagnostic portfolio. ITC's...
...sold its International Technidyne Corp. (ITC) subsidiary to Warburg Pincus for $55 million in cash. ITC...
BioCentury | Jul 22, 2010
Distillery Therapeutics

Indication: Autoimmune disease

...Okano Keio University, Tokyo, Japan e-mail: hidokano@sc.itc.keio.ac.jp Contact: Masaya Nakamura, same affiliation as above e-mail: masa@sc.itc.keio.ac.jp...
BioCentury | Jul 22, 2010
Distillery Therapeutics

Indication: Neurology

...Okano Keio University, Tokyo, Japan e-mail: hidokano@sc.itc.keio.ac.jp Contact: Masaya Nakamura, same affiliation as above e-mail: masa@sc.itc.keio.ac.jp BC...
BioCentury | Jul 1, 2010
Distillery Therapeutics

Indication: Cardiovascular disease

...June 14, 2010; doi:10.1172/JCI40973 Contact: Keiichi Fukuda, Keio University School of Medicine, Tokyo, Japan e-mail: kfukuda@sc.itc.keio.ac.jp BC...
Items per page:
1 - 10 of 47
BioCentury | Mar 6, 2021
Politics, Policy & Law

PTAB expected to get a Supreme pass

...operate, such as the International Trade Commission (ITC...
BioCentury | Oct 20, 2014
Company News

Xagenic management update

...CEO and a director, formerly president and CEO of Accumetrics Inc. , which merged with ITC Nexus Holding Co....
BioCentury | May 5, 2014
Company News

Acasti, Enzymotec, Neptune Technologies nutraceuticals news

...agreement related to Neptune's patents for marine omega-3 phospholipids , ending an International Trade Commission (ITC...
...products infringed the '348 patent, along with Neptune's U.S. Patent Nos. 8,278,351 and 8,383,675. The ITC...
BioCentury | Feb 3, 2014
Emerging Company Profile

2bind: Results within minutes

...said sample prep for standard approaches, such as surface plasmon resonance (SPR), isothermal titration calorimetry (ITC...
...interaction under multiple reaction conditions. This is generally not the case for analysis via SPR, ITC...
...crude extracts such as sera and lysates, whereas trying to do so with SPR or ITC...
BioCentury | Nov 21, 2011
Company News

ITC, Samsung Electronics Co. Ltd. deal

...Samsung will acquire the Nexus Dx Inc. division of ITC for an undisclosed amount. ITC said...
...monitoring cardiovascular diseases. The deal is expected to close this quarter. Terms were not disclosed. ITC...
BioCentury | Oct 6, 2011
Distillery Techniques

Technology: Drug platforms

...Okano, Keio University, Tokyo, Japan e-mail: hidokano@a2.keio.jp Contact: Masaya Nakamura, same affiliation as above e-mail: masa@sc.itc.keio.ac.jp BC...
BioCentury | Nov 15, 2010
Company News

Nexus Dx Inc., Thoratec, Warburg Pincus deal

...sold its International Technidyne Corp. (ITC) subsidiary to Warburg Pincus for $55 million in cash. ITC...
...merged with Warburg-investment Nexus Dx. Nexus said the deal will expand its point-of-care diagnostic portfolio. ITC's...
...sold its International Technidyne Corp. (ITC) subsidiary to Warburg Pincus for $55 million in cash. ITC...
BioCentury | Jul 22, 2010
Distillery Therapeutics

Indication: Autoimmune disease

...Okano Keio University, Tokyo, Japan e-mail: hidokano@sc.itc.keio.ac.jp Contact: Masaya Nakamura, same affiliation as above e-mail: masa@sc.itc.keio.ac.jp...
BioCentury | Jul 22, 2010
Distillery Therapeutics

Indication: Neurology

...Okano Keio University, Tokyo, Japan e-mail: hidokano@sc.itc.keio.ac.jp Contact: Masaya Nakamura, same affiliation as above e-mail: masa@sc.itc.keio.ac.jp BC...
BioCentury | Jul 1, 2010
Distillery Therapeutics

Indication: Cardiovascular disease

...June 14, 2010; doi:10.1172/JCI40973 Contact: Keiichi Fukuda, Keio University School of Medicine, Tokyo, Japan e-mail: kfukuda@sc.itc.keio.ac.jp BC...
Items per page:
1 - 10 of 47